BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1624025)

  • 1. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M
    Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two different doses of leuprolide acetate depot on uterine cavity area in patients with uterine leiomyomata.
    Watanabe Y; Nakamura G
    Fertil Steril; 1995 Mar; 63(3):487-90. PubMed ID: 7851574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
    Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
    J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ
    Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
    Aleem FA; Predanic M
    Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.
    Bhatia S; Neely EK; Wilson DM
    Pediatrics; 2002 Feb; 109(2):E30. PubMed ID: 11826240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
    Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
    Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S; Affinito P; Tommaselli GA; Nappi C
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.